TEAM.NASDAQAtlassian CORP

Form 4: Atlassian Co-CEO Michael Cannon-Brookes Sells Class A Common Stock

Sentiment:

SEC Form 4


Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, executed multiple sales of Class A Common Stock on July 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On July 9, 2024, Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, sold Class A Common Stock.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
  • The transactions involved multiple trades at varying prices, ranging from $177.09 to $181.88 per share.
  • The sales resulted in a decrease in the number of shares indirectly beneficially owned by Cannon-Brookes through a trust.
  • The reporting person undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions under a pre-arranged plan.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. It is important to note that the sales were executed under a pre-arranged 10b5-1 trading plan, which is a common practice to avoid accusations of insider trading.

Stakeholder Impact

  • The sale of shares by a high-profile executive could potentially create short-term uncertainty among shareholders.
  • However, the existence of a pre-arranged trading plan mitigates concerns about insider information being used for personal gain.

Key Dates

DateDescription
02/08/2024Date of adoption of Rule 10b5-1 trading plan.
07/09/2024Date of the reported transactions (sales of Class A Common Stock).
07/10/2024Date of signature of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.